Header Logo

Connection

CHARLES F LEVENBACK to Uterine Cervical Neoplasms

Back to Details
This is a "connection" page, showing publications CHARLES F LEVENBACK has written about Uterine Cervical Neoplasms.
CHARLES F LEVENBACK
Connection Strength
2.766
Uterine Cervical Neoplasms
  1. "Triple injection" lymphatic mapping technique to determine if parametrial nodes are the true sentinel lymph nodes in women with cervical cancer. Gynecol Oncol. 2012 Dec; 127(3):467-71.
    View in: PubMed
    Score: 0.189
  2. New or not? Difficulties recognizing innovation. Gynecol Oncol. 2010 Jun; 117(3):399-400.
    View in: PubMed
    Score: 0.162
  3. Lymphatic mapping and sentinel lymph node detection in women with cervical cancer. Gynecol Oncol. 2008 Sep; 110(3 Suppl 2):S17-20.
    View in: PubMed
    Score: 0.141
  4. Status of sentinel lymph nodes in cervical cancer. Gynecol Oncol. 2007 Oct; 107(1 Suppl 1):S18-9.
    View in: PubMed
    Score: 0.134
  5. Retroperitoneal lymph node resection in patients with cervical cancer. Surg Oncol. 2006 Aug; 15(2):79-83.
    View in: PubMed
    Score: 0.126
  6. Usefulness of preoperative lymphoscintigraphy in patients who undergo radical hysterectomy and pelvic lymphadenectomy for cervical cancer. Am J Obstet Gynecol. 2006 Apr; 194(4):1186-93; discussion 1193-5.
    View in: PubMed
    Score: 0.121
  7. Total laparoscopic radical hysterectomy and lymphadenectomy: the M. D. Anderson Cancer Center experience. Gynecol Oncol. 2006 Aug; 102(2):252-5.
    View in: PubMed
    Score: 0.120
  8. Phase II trial of capecitabine in recurrent squamous cell carcinoma of the cervix. Gynecol Oncol. 2005 Jun; 97(3):840-4.
    View in: PubMed
    Score: 0.115
  9. Radical trachelectomy: is it here to stay? Gynecol Oncol. 2004 Sep; 94(3):611-3.
    View in: PubMed
    Score: 0.109
  10. Lymphatic mapping and sentinel node identification in patients with cervix cancer undergoing radical hysterectomy and pelvic lymphadenectomy. J Clin Oncol. 2002 Feb 01; 20(3):688-93.
    View in: PubMed
    Score: 0.091
  11. Sentinel nodes in gynecologic malignancies. Curr Opin Oncol. 2001 Sep; 13(5):403-7.
    View in: PubMed
    Score: 0.088
  12. Sensitivity and negative predictive value for sentinel lymph node biopsy in women with early-stage cervical cancer. Gynecol Oncol. 2017 04; 145(1):96-101.
    View in: PubMed
    Score: 0.064
  13. Hemorrhagic cystitis following radiotherapy for stage Ib cancer of the cervix. Gynecol Oncol. 1994 Nov; 55(2):206-10.
    View in: PubMed
    Score: 0.055
  14. Successful percutaneous drainage of gluteal pyomyositis occurring after intra-arterial chemotherapy and pelvic irradiation. Gynecol Oncol. 1994 Jun; 53(3):376-9.
    View in: PubMed
    Score: 0.053
  15. Advanced gynecologic malignancies treated with a combination of the VEGF inhibitor bevacizumab and the mTOR inhibitor temsirolimus. Oncotarget. 2014 Apr 15; 5(7):1846-55.
    View in: PubMed
    Score: 0.053
  16. Sentinel lymph node evaluation in women with cervical cancer. J Minim Invasive Gynecol. 2014 Jul-Aug; 21(4):540-5.
    View in: PubMed
    Score: 0.052
  17. Anatomic distribution of fluorodeoxyglucose-avid para-aortic lymph nodes in patients with cervical cancer. Int J Radiat Oncol Biol Phys. 2013 Mar 15; 85(4):1045-50.
    View in: PubMed
    Score: 0.049
  18. Endoluminal ultrasound staging of cervical cancer. Gynecol Oncol. 1992 Aug; 46(2):186-90.
    View in: PubMed
    Score: 0.047
  19. Laparoscopic sentinel node procedure in patients with cervical cancer. J Clin Oncol. 2002 May 15; 20(10):2602-3; author reply 2603.
    View in: PubMed
    Score: 0.046
  20. The quality of cervical cancer brachytherapy implantation and the impact on local recurrence and disease-free survival in radiation therapy oncology group prospective trials 0116 and 0128. Int J Gynecol Cancer. 2012 Jan; 22(1):123-31.
    View in: PubMed
    Score: 0.045
  21. Extended-field irradiation and intracavitary brachytherapy combined with cisplatin and amifostine for cervical cancer with positive para-aortic or high common iliac lymph nodes: results of arm II of Radiation Therapy Oncology Group (RTOG) 0116. Int J Gynecol Cancer. 2011 Oct; 21(7):1266-75.
    View in: PubMed
    Score: 0.044
  22. Radical hysterectomy: a comparison of surgical approaches after adoption of robotic surgery in gynecologic oncology. Gynecol Oncol. 2011 Nov; 123(2):333-6.
    View in: PubMed
    Score: 0.044
  23. Concurrent chemoradiation in the routine management of patients with cervical cancer: does marital status matter? Int J Gynecol Cancer. 2009 Aug; 19(6):1107-12.
    View in: PubMed
    Score: 0.038
  24. Parametrial involvement in radical hysterectomy specimens for women with early-stage cervical cancer. Obstet Gynecol. 2009 Jul; 114(1):93-99.
    View in: PubMed
    Score: 0.038
  25. Evaluation of intervention to prevent hypomagnesemia in cervical cancer patients receiving combination cisplatin and radiation treatment. Support Care Cancer. 2009 Sep; 17(9):1195-201.
    View in: PubMed
    Score: 0.037
  26. Predictive value of a proposed subclassification of stages I and II cervical cancer based on clinical tumor diameter. Int J Gynecol Cancer. 2009 Jan; 19(1):2-7.
    View in: PubMed
    Score: 0.037
  27. A phase III randomized clinical trial comparing laparoscopic or robotic radical hysterectomy with abdominal radical hysterectomy in patients with early stage cervical cancer. J Minim Invasive Gynecol. 2008 Sep-Oct; 15(5):584-8.
    View in: PubMed
    Score: 0.036
  28. Comparison of treatment tolerance and outcomes in patients with cervical cancer treated with concurrent chemoradiotherapy in a prospective randomized trial or with standard treatment. Int J Radiat Oncol Biol Phys. 2008 Jan 01; 70(1):118-25.
    View in: PubMed
    Score: 0.034
  29. Modified uterine manipulator and vaginal rings for total laparoscopic radical hysterectomy. Int J Gynecol Cancer. 2008 May-Jun; 18(3):571-5.
    View in: PubMed
    Score: 0.033
  30. Extended-field irradiation and intracavitary brachytherapy combined with cisplatin chemotherapy for cervical cancer with positive para-aortic or high common iliac lymph nodes: results of ARM 1 of RTOG 0116. Int J Radiat Oncol Biol Phys. 2007 Jul 15; 68(4):1081-7.
    View in: PubMed
    Score: 0.032
  31. Time course and outcome of central recurrence after radiation therapy for carcinoma of the cervix. Int J Gynecol Cancer. 2006 May-Jun; 16(3):1106-11.
    View in: PubMed
    Score: 0.031
  32. Phase II study of tirapazamine plus cisplatin in patients with advanced or recurrent cervical cancer. Int J Gynecol Cancer. 2006 May-Jun; 16(3):1165-71.
    View in: PubMed
    Score: 0.031
  33. Quality of life and sexual functioning in cervical cancer survivors. J Clin Oncol. 2005 Oct 20; 23(30):7428-36.
    View in: PubMed
    Score: 0.029
  34. Role of surgical resection for lung, liver, and central nervous system metastases in patients with gynecological cancer: a literature review. Int J Gynecol Cancer. 2004 May-Jun; 14(3):399-422.
    View in: PubMed
    Score: 0.027
  35. Small cell neuroendocrine carcinoma of the cervix: outcome and patterns of recurrence. Gynecol Oncol. 2004 Apr; 93(1):27-33.
    View in: PubMed
    Score: 0.026
  36. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01. J Clin Oncol. 2004 Mar 01; 22(5):872-80.
    View in: PubMed
    Score: 0.026
  37. Imaging in cervical cancer. Cancer. 2003 Nov 01; 98(9 Suppl):2028-38.
    View in: PubMed
    Score: 0.026
  38. Correlation of smoking history and other patient characteristics with major complications of pelvic radiation therapy for cervical cancer. J Clin Oncol. 2002 Sep 01; 20(17):3651-7.
    View in: PubMed
    Score: 0.024
  39. Phase II study of carboplatin and liposomal doxorubicin in patients with recurrent squamous cell carcinoma of the cervix. Cancer. 2001 Nov 01; 92(9):2327-33.
    View in: PubMed
    Score: 0.022
  40. Sigmoid perforation following radiation therapy in patients with cervical cancer. Gynecol Oncol. 2001 Jul; 82(1):150-5.
    View in: PubMed
    Score: 0.022
  41. A Phase II study of topotecan in patients with squamous cell carcinoma of the cervix: a gynecologic oncology group study. Gynecol Oncol. 2001 May; 81(2):213-5.
    View in: PubMed
    Score: 0.022
  42. Posttherapy surveillance of women with cervical cancer: an outcomes analysis. Gynecol Oncol. 2000 Aug; 78(2):187-93.
    View in: PubMed
    Score: 0.020
  43. Intraoperative lymphatic mapping and sentinel node identification: gynecologic applications. Recent Results Cancer Res. 2000; 157:150-8.
    View in: PubMed
    Score: 0.020
  44. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med. 1999 Apr 15; 340(15):1137-43.
    View in: PubMed
    Score: 0.019
  45. A phase II trial of CPT-11 in recurrent squamous carcinoma of the cervix: a gynecologic oncology group study. Gynecol Oncol. 1998 Sep; 70(3):334-8.
    View in: PubMed
    Score: 0.018
  46. A phase II study of prolonged oral etoposide in advanced or recurrent carcinoma of the cervix. Gynecol Oncol. 1998 Aug; 70(2):215-8.
    View in: PubMed
    Score: 0.018
  47. Chemotherapy for cervical carcinoma: factors determining response and implications for clinical trial design. J Clin Oncol. 1998 May; 16(5):1879-84.
    View in: PubMed
    Score: 0.018
  48. Phase II study of vinorelbine in advanced and recurrent squamous cell carcinoma of the cervix. J Clin Oncol. 1998 Mar; 16(3):1094-8.
    View in: PubMed
    Score: 0.017
  49. The effect of dietary fiber on bowel function following radical hysterectomy: a randomized trial. Gynecol Oncol. 1997 Sep; 66(3):417-24.
    View in: PubMed
    Score: 0.017
  50. Adenocarcinoma in situ of the cervix: significance of cone biopsy margins. Obstet Gynecol. 1996 Jul; 88(1):82-6.
    View in: PubMed
    Score: 0.015
  51. Adenocarcinoma of the cervix in a renal transplant patient. Gynecol Oncol. 1995 Oct; 59(1):151-5.
    View in: PubMed
    Score: 0.015
  52. Time course and incidence of late complications in patients treated with radiation therapy for FIGO stage IB carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys. 1995 Jul 30; 32(5):1289-300.
    View in: PubMed
    Score: 0.014
  53. Pelvic exenteration for adenocarcinoma of the uterine cervix. Gynecol Oncol. 1995 Jul; 58(1):74-8.
    View in: PubMed
    Score: 0.014
  54. Treatment of locally advanced cervical cancer with concurrent radiation and intra-arterial chemotherapy. Gynecol Oncol. 1995 Apr; 57(1):72-8.
    View in: PubMed
    Score: 0.014
  55. Ureteral stricture as a late complication of radiotherapy for stage IB carcinoma of the uterine cervix. Cancer. 1995 Feb 01; 75(3):836-43.
    View in: PubMed
    Score: 0.014
  56. A phase II study of carboplatin and cisplatin in advanced or recurrent squamous carcinoma of the uterine cervix. Gynecol Oncol. 1994 May; 53(2):234-8.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.